{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:48:26Z","timestamp":1764172106887,"version":"3.40.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T00:00:00Z","timestamp":1392854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"DOI":"10.1007\/s00430-014-0329-2","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T12:35:57Z","timestamp":1392813357000},"source":"Crossref","is-referenced-by-count":6,"title":["Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients"],"prefix":"10.1007","author":[{"given":"Katia","family":"Monteleone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cacciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Falasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Fraulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Falciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivano","family":"Mezzaroma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"D\u2019Ettorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ombretta","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Scagnolari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,20]]},"reference":[{"issue":"Suppl 3","key":"329_CR1","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"66","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH (2006) IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 66(Suppl 3):iii61\u2013iii64","journal-title":"Ann Rheum Dis"},{"doi-asserted-by":"crossref","unstructured":"Joosten LA, Heinhuis B, Netea MG, Dinarello CA (2013) Novel insights into the biology of interleukin-32. Cell Mol Life Sci (Epub ahead of print)","key":"329_CR2","DOI":"10.1007\/s00018-013-1301-9"},{"key":"329_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SH (2009) Identification of the most active interleukin-32 isoform. Immunology 126:535\u2013542. doi: 10.1111\/j.1365-2567.2008.02917.x","journal-title":"Immunology"},{"key":"329_CR4","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1073\/pnas.0511206103","volume":"103","author":"D Novick","year":"2006","unstructured":"Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH (2006) Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 103:3316\u20133321","journal-title":"Proc Natl Acad Sci USA"},{"key":"329_CR5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5483\/BMBRep.2008.41.11.814","volume":"41","author":"S Kim","year":"2008","unstructured":"Kim S, Lee S, Her E, Bae S, Choi J, Hong J, Jaekal J, Yoon D, Azam T, Dinarello CA, Kim S (2008) Proteinase 3-processed form of the recombinant IL-32 separate domain. BMB Rep 41:814\u2013819","journal-title":"BMB Rep"},{"key":"329_CR6","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","volume":"185","author":"W Li","year":"2010","unstructured":"Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y (2010) IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 185:5056\u20135065. doi: 10.4049\/jimmunol.0902667","journal-title":"J Immunol"},{"key":"329_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2011.12.024","volume":"58","author":"S Bae","year":"2012","unstructured":"Bae S, Kang D, Hong J, Chung B, Choi J, Jhun H, Hong K, Kim E, Jo S, Lee S, Kim SH, Kim S (2012) Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine 58:79\u201386. doi: 10.1016\/j.cyto.2011.12.024","journal-title":"Cytokine"},{"key":"329_CR8","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","volume":"53","author":"AR Moschen","year":"2011","unstructured":"Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H (2011) Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology 53:1819\u20131829. doi: 10.1002\/hep.24285","journal-title":"Hepatology"},{"key":"329_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2012.05.009","volume":"65","author":"Q Xu","year":"2012","unstructured":"Xu Q, Pan X, Shu X, Cao H, Li X, Zhang K, Lu J, Zou Y, Li X, Liu H, Zhang Y, Yang D, Ning Q, Shen G, Li GJ (2012) Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect 65:336\u2013342. doi: 10.1016\/j.jinf.2012.05.009","journal-title":"J Infect"},{"key":"329_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","volume":"132","author":"S Lee","year":"2011","unstructured":"Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y, Kim J, Park J, Park S, Hong J, Yoon DY (2011) Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 132:410\u2013420. doi: 10.1111\/j.1365-2567.2010.03377.x","journal-title":"Immunology"},{"key":"329_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","volume":"117","author":"ST Rasool","year":"2008","unstructured":"Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, Mu Y, Xing HX, Wu J, Zhu Y (2008) Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 117:161\u2013167. doi: 10.1016\/j.imlet.2008.01.007","journal-title":"Immunol Lett"},{"key":"329_CR12","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.1100277","volume":"186","author":"AJ Smith","year":"2011","unstructured":"Smith AJ, Toledo CM, Wietgrefe SW, Duan L, Schacker TW, Reilly CS, Haase AT (2011) The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J Immunol 186:6576\u20136584. doi: 10.4049\/jimmunol.1100277","journal-title":"J Immunol"},{"key":"329_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","volume":"81","author":"MF Nold","year":"2008","unstructured":"Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA (2008) Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 81:557\u2013565","journal-title":"J Immunol"},{"key":"329_CR14","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","volume":"186","author":"JA Zepp","year":"2011","unstructured":"Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF (2011) Protection from RNA and DNA viruses by IL-32. J Immunol 186:4110\u20134118. doi: 10.4049\/jimmunol.1000081","journal-title":"J Immunol"},{"issue":"29","key":"329_CR15","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1074\/jbc.M112.440115","volume":"288","author":"Y Li","year":"2013","unstructured":"Li Y, Xie J, Xu X, Liu L, Wan Y, Liu Y, Zhu C, Zhu Y (2013) Inducible IL-32 exerts extensive antiviral function via selective stimulation of IFN-\u03bb1. J Biol Chem 288(29):20927\u201320941. doi: 10.1074\/jbc.M112.440115","journal-title":"J Biol Chem"},{"key":"329_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-5-51","volume":"5","author":"R Goila-Gaur","year":"2008","unstructured":"Goila-Gaur R, Strebel K (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51. doi: 10.1186\/1742-4690-5-51","journal-title":"Retrovirology"},{"issue":"6898","key":"329_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418(6898):646\u2013650","journal-title":"Nature"},{"issue":"11","key":"329_CR18","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1128\/JVI.78.11.6073-6076.2004","volume":"78","author":"YH Zheng","year":"2004","unstructured":"Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78(11):6073\u20136076","journal-title":"J Virol"},{"key":"329_CR19","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399409001343","volume":"12","author":"JS Albin","year":"2010","unstructured":"Albin JS, Harris RS (2010) Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med 12:e4. doi: 10.1017\/S1462399409001343","journal-title":"Expert Rev Mol Med"},{"key":"329_CR20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/QAI.0b013e3180315515","volume":"44","author":"O Turriziani","year":"2007","unstructured":"Turriziani O, Bucci M, Stano A, Scagnolari C, Bellomi F, Fimiani C, Mezzaroma I, D\u2019Ettorre G, Brogi A, Vullo V, Antonelli G (2007) Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals. J Acquir Immune Defic Syndr 44:518\u2013524","journal-title":"J Acquir Immune Defic Syndr"},{"key":"329_CR21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/CVI.00445-08","volume":"16","author":"C Scagnolari","year":"2009","unstructured":"Scagnolari C, Midulla F, Pierangeli A, Moretti C, Bonci E, Berardi R, De Angelis D, Selvaggi C, Di Marco P, Girardi E, Antonelli G (2009) Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 16:816\u2013823","journal-title":"Clin Vaccine Immunol"},{"key":"329_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1398-9995.2011.02706.x","volume":"67","author":"A Keswani","year":"2012","unstructured":"Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, Chandra R, Kim SH, Azam T, Dinarello CA, Kern RC, Schleimer RP, Kato A (2012) Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 67:25\u201332. doi: 10.1111\/j.1398-9995.2011.02706.x","journal-title":"Allergy"},{"issue":"13","key":"329_CR23","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkq174","volume":"38","author":"EW Refsland","year":"2010","unstructured":"Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucl Acids Res 38(13):4274\u20134284. doi: 10.1093\/nar\/gkq174","journal-title":"Nucl Acids Res"},{"issue":"8","key":"329_CR24","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","volume":"3","author":"MG Netea","year":"2006","unstructured":"Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA (2006) Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1\/IL-18\/interferon-gamma-dependent mechanism. PLoS Med 3(8):e277","journal-title":"PLoS Med"},{"key":"329_CR25","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.0901913","volume":"184","author":"X Bai","year":"2010","unstructured":"Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA, Chan ED (2010) IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol 184:3830\u20133840. doi: 10.4049\/jimmunol.0901913","journal-title":"J Immunol"},{"key":"329_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1743-422X-10-51","volume":"10","author":"Y Huang","year":"2013","unstructured":"Huang Y, Qi Y, Ma Y, He R, Ji Y, Sun Z, Ruan Q (2013) The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1. Virol J 10:51. doi: 10.1186\/1743-422X-10-51","journal-title":"Virol J"},{"issue":"10","key":"329_CR27","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","volume":"203","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, Tracy RP, Corey L, Deeks SG (2011) Valganciclovir reduces T cell activation in HIV-infected individuals within complete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203(10):1474\u20131483. doi: 10.1093\/infdis\/jir060","journal-title":"J Infect Dis"},{"key":"329_CR28","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1038\/srep02960","volume":"3","author":"M Nakayama","year":"2013","unstructured":"Nakayama M, Niki Y, Kawasaki T, Takeda Y, Ikegami H, Toyama Y, Miyamoto T (2013) IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis. Sci Rep 3:2960. doi: 10.1038\/srep02960","journal-title":"Sci Rep"},{"key":"329_CR29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-009-9360-2","volume":"30","author":"YG Kim","year":"2010","unstructured":"Kim YG, Lee CK, Kim SH, Cho WS, Mun SH, Yoo B (2010) Interleukin-32\u03b3 enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1\/2 activation. J Clin Immunol 30:260\u2013267. doi: 10.1007\/s10875-009-9360-2","journal-title":"J Clin Immunol"},{"key":"329_CR30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1743-422X-7-311","volume":"7","author":"C Scagnolari","year":"2010","unstructured":"Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G, Riva E, Pizzigallo E, Antonelli G (2010) Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J 7:311. doi: 10.1186\/1743-422X-7-311","journal-title":"Virol J"},{"key":"329_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2010.0076","volume":"31","author":"O Haller","year":"2011","unstructured":"Haller O, Kochs G (2011) Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31:79\u201387. doi: 10.1089\/jir 2010.0076","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"329_CR32","doi-asserted-by":"crossref","first-page":"e15200","DOI":"10.1371\/journal.pone.0015200","volume":"5","author":"J Diegelmann","year":"2010","unstructured":"Diegelmann J, Beigel F, Zitzmann K, Kaul A, G\u00f6ke B, Auernhammer CJ, Bartenschlager R, Diepolder HM, Brand S (2010) Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS ONE 5(12):e15200. doi: 10.1371\/journal.pone.0015200","journal-title":"PLoS ONE"},{"key":"329_CR33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","volume":"30","author":"RP Donnelly","year":"2010","unstructured":"Donnelly RP, Kotenko SV (2010) Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 30:555\u2013564. doi: 10.1089\/jir.2010.0078","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"329_CR34","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1128\/JVI.01773-08","volume":"83","author":"W Hou","year":"2009","unstructured":"Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ (2009) Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol 83(8):3834\u20133842. doi: 10.1128\/JVI.01773-08","journal-title":"J Virol"},{"issue":"5","key":"329_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/14712598.2013.764409","volume":"13","author":"C Scagnolari","year":"2013","unstructured":"Scagnolari C, Antonelli G (2013) Antiviral activity of the interferon \u03b1 family: biological and pharmacological aspects of the treatment of chronic hepatitis C. Expert Opin Biol Ther 13(5):693\u2013711. doi: 10.1517\/14712598.2013.764409","journal-title":"Expert Opin Biol Ther"},{"key":"329_CR36","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH (2005) IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102:16309\u201316314","journal-title":"Proc Natl Acad Sci USA"},{"key":"329_CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2012.06.001","volume":"23","author":"G Marsili","year":"2012","unstructured":"Marsili G, Remoli AL, Sgarbanti M, Perrotti E, Fragale A, Battistini A (2012) HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion. Cytokine Growth Factor Rev 23:255\u2013270. doi: 10.1016\/j.cytogfr.2012.06.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"329_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3461","volume":"13","author":"M Papatriantafyllou","year":"2013","unstructured":"Papatriantafyllou M (2013) Infection: the interferon paradox. Nat Rev Immunol 13(6):392. doi: 10.1038\/nri3461","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"329_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/rmv.1708","volume":"22","author":"R Hughes","year":"2012","unstructured":"Hughes R, Towers G, Noursadeghi M (2012) Innate immune interferon responses to human immunodeficiency virus-1 infection. Rev Med Virol 22(4):257\u2013266. doi: 10.1002\/rmv.1708","journal-title":"Rev Med Virol"},{"issue":"1","key":"329_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2012.04.011","volume":"95","author":"RR Tian","year":"2012","unstructured":"Tian RR, Guo HX, Wei JF, Yang CK, He SH, Wang JH (2012) IFN-\u03bb inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production. Antiviral Res 95(1):57\u201365. doi: 10.1016\/j.antiviral.2012.04.011","journal-title":"Antiviral Res"},{"key":"329_CR41","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","volume":"106","author":"CA Nold-Petry","year":"2009","unstructured":"Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA (2009) IL-32-dependent effects of IL-1\u03b2 on endothelial cell functions. Proc Natl Acad Sci USA 106:3883\u20133888. doi: 10.1073\/pnas.0813334106","journal-title":"Proc Natl Acad Sci USA"},{"key":"329_CR42","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1073\/pnas.1016005108","volume":"108","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA (2011) Inflammation-dependent secretion and splicing of IL-32\u03b3 in rheumatoid arthritis. Proc Natl Acad Sci USA 108:4962\u20134967. doi: 10.1073\/pnas.1016005108","journal-title":"Proc Natl Acad Sci USA"},{"key":"329_CR43","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/carcin\/bgt092","volume":"34","author":"TS Plantinga","year":"2013","unstructured":"Plantinga TS, Costantini I, Heinhuis B, Huijbers A, Semango G, Kusters B, Netea MG, Hermus AR, Smit JW, Dinarello CA, Joosten LA, Netea-Maier RT (2013) A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma. Carcinogenesis 34:1529\u20131535. doi: 10.1093\/carcin\/bgt092.Epub","journal-title":"Carcinogenesis"},{"key":"329_CR44","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1074\/jbc.M900368200","volume":"284","author":"A Nishida","year":"2009","unstructured":"Nishida A, Andoh A, Inatomi O, Fujiyama Y (2009) Interleukin-32 expression in the pancreas. J Biol Chem 284:17868\u201317876. doi: 10.1074\/jbc.M900368200","journal-title":"J Biol Chem"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0329-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-014-0329-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0329-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T21:54:26Z","timestamp":1746136466000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-014-0329-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,20]]},"references-count":44,"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s00430-014-0329-2","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2014,2,20]]}}}